Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-07-17
1991-06-25
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548550, C07D20726, C07D207335, A61K 3140
Patent
active
050268619
ABSTRACT:
Novel cyclic vinylogous N-hydroxy-N-methylureas are useful in the treatment of leukotriene mediated conditions such as asthma and rheumatoid arthritis.
REFERENCES:
Summers, J. B., et al., J. Med. Chem., 30, 574-580, 1987.
Summers, J. B., et al., J. Med. Chem., 30, 2121-2126.
Tateson, J. E., et al., Br. J. Pharmacol., 94, 528-539.
Beight Douglas W.
Flynn Gary A.
Merrell Dow Pharmaceuticals
Rotman Alan L.
Stein William J.
LandOfFree
Substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-on does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-on, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-on will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1041201